Search hospitals > California > Garden Grove
Collaborative NeuroScience Network, Inc.
Claim this profileGarden Grove, California 92845
Global Leader in Schizophrenia
Global Leader in Depression
Conducts research for Major Depressive Disorder
Conducts research for Psychosis
Conducts research for Alzheimer's Disease
70 reported clinical trials
1 medical researcher
Summary
Collaborative NeuroScience Network, Inc. is a medical facility located in Garden Grove, California. This center is recognized for care of Schizophrenia, Depression, Major Depressive Disorder, Psychosis, Alzheimer's Disease and other specialties. Collaborative NeuroScience Network, Inc. is involved with conducting 70 clinical trials across 35 conditions. There are 1 research doctors associated with this hospital, such as Dr. David Walling.Area of expertise
1Schizophrenia
Global LeaderCYP2D6
2Depression
Global LeaderSelective Serotonin Reuptake Inhibitors (SSRI)
Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)
Top PIs
Clinical Trials running at Collaborative NeuroScience Network, Inc.
Schizophrenia
Long-term Safety of Iclepertin
for Schizophrenia
This study is open to adults with schizophrenia who took part in a previous CONNEX study (study 1346-0011, 1346-0012, or 1346-0013). The purpose of this study is to find out how well people with schizophrenia can tolerate a medicine called Iclepertin in the long term. Participants take Iclepertin as tablets once a day for 1 year. In addition, all participants take their normal medication for schizophrenia. Participants are in the study for a little more than 1 year. During this time, they visit the study site about 13 times and get about 9 phone calls from the study team. The doctors collect information on any health problems of the participants. Doctors also regularly check the participants' symptoms of schizophrenia.
Recruiting2 awards Phase 35 criteria
Iclepertin
for Schizophrenia
This trial tests if a medicine called Iclepertin can help improve memory and learning in adults with schizophrenia. Participants take Iclepertin daily while continuing their usual medication. Doctors regularly check their mental abilities and health throughout the study. Iclepertin is being studied for its potential to improve cognitive functions in schizophrenia.
Recruiting1 award Phase 311 criteria
KarXT
for Schizophrenia
This trial tests KarXT, a combination of two drugs, for people who haven't improved with their current treatment. KarXT aims to balance brain functions and reduce side effects. The study will look at improvements in health and daily life. KarXT has shown positive results in earlier tests.
Recruiting1 award Phase 321 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Collaborative NeuroScience Network, Inc.?
Collaborative NeuroScience Network, Inc. is a medical facility located in Garden Grove, California. This center is recognized for care of Schizophrenia, Depression, Major Depressive Disorder, Psychosis, Alzheimer's Disease and other specialties. Collaborative NeuroScience Network, Inc. is involved with conducting 70 clinical trials across 35 conditions. There are 1 research doctors associated with this hospital, such as Dr. David Walling.